Venkata N. Konanki, MD
Pediatrics · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Konanki’s office at (916) 298-2721 to ask if they take your plan before you enroll.
Medicaid work
$96,354 in 2024
Medicaid paid $96,354 for 1,757 billed services this clinician did in 2024, up to 47 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 414 | $23,801 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 345 | $19,232 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 182 | $16,175 |
| Return visit (30+ min) | 170 | $13,281 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 144 | $12,427 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 60 | $5,239 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; each additional vaccine or toxoid component administered (List separately in addition to code for primary procedure) | 114 | $4,790 |
| Developmental screening | 29 | $830 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 24 | $512 |
| Administration of caregiver-focused health risk assessment instrument (eg, depression inventory) for the benefit of the patient, with scoring and documentation, per standardized instrument | 141 | $44 |
| Bilateral quantitative screening test of visual acuity | 13 | $22 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 19 | $0 |
| 2024 | 1,757 | 16 | 47 | $96,354 |
| 2023 | 1,647 | 15 | 64 | $84,227 |
| 2022 | 1,798 | 12 | 75 | $100,072 |
| 2021 | 1,089 | 10 | 71 | $53,588 |
| 2020 | 2,222 | 20 | 161 | $173,913 |
| 2019 | 3,516 | 21 | 155 | $282,959 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 535 | $30,432 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 304 | $16,753 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 182 | $15,609 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 122 | $10,330 |
| Return visit (30+ min) | 95 | $7,283 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 28 | $2,458 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; each additional vaccine or toxoid component administered (List separately in addition to code for primary procedure) | 16 | $705 |
| Developmental screening | 12 | $322 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 17 | $321 |
| Administration of patient-focused health risk assessment instrument (eg, health hazard appraisal) with scoring and documentation, per standardized instrument | 113 | $14 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 63 | $0 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 20 | $0 |
2022
| Short return visit (20+ min) | 766 | $43,942 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 319 | $18,697 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 181 | $15,425 |
| Return visit (30+ min) | 154 | $11,868 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 83 | $7,610 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 15 | $1,210 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 42 | $876 |
| Developmental screening | 15 | $349 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 31 | $95 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 35 | $0 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 26 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 131 | $0 |
2021
| Short return visit (20+ min) | 564 | $31,578 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 262 | $11,105 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 77 | $6,461 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 25 | $2,160 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 13 | $1,174 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 27 | $555 |
| OCULAR INSTRUMNT SCREEN BIL | 14 | $316 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; Streptococcus, group A | 13 | $203 |
| Administration of caregiver-focused health risk assessment instrument (eg, depression inventory) for the benefit of the patient, with scoring and documentation, per standardized instrument | 15 | $37 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 79 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 637 | $165,946 |
| Short return visit (20+ min) | 266 | $5,229 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 72 | $2,236 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 216 | $501 |
| Measurement of lead | 12 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure) | 115 | $0 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 12 | $0 |
| Haemophilus influenzae type b vaccine, PRP-OMP conjugate | 32 | $0 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 56 | $0 |
| Rotavirus vaccine, human, attenuated (RV1), 2 dose schedule, live, for oral use | 14 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 165 | $0 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, hepatitis B, and inactivated poliovirus vaccine (DTaP-HepB-IPV), for intramuscular use | 33 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 1,097 | $282,959 |
| Puncture of skin for collection of blood sample | 26 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 343 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure) | 189 | $0 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 26 | $0 |
| Haemophilus influenzae type b vaccine, PRP-OMP conjugate | 27 | $0 |
| Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 2 or 3 dose schedule, for intramuscular use | 19 | $0 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 93 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 137 | $0 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, hepatitis B, and inactivated poliovirus vaccine (DTaP-HepB-IPV), for intramuscular use | 30 | $0 |
| Meningococcal conjugate vaccine, serogroups A, C, W, Y, quadrivalent, diphtheria toxoid carrier (MenACWY-D) or CRM197 carrier (MenACWY-CRM), for intramuscular use | 12 | $0 |
| Screening test, pure tone, air only | 221 | $0 |
Money from drug and device companies
$96 in 2025
| 2025 | 4 | 4 | None | $96 |
| 2024 | 3 | 4 | None | $78 |
| 2023 | 5 | 5 | None | $107 |
| 2022 | 5 | 5 | None | $101 |
| 2021 | 1 | 2 | None | $28 |
| 2020 | 1 | 1 | None | $11 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Sanofi Pasteur | Beyfortus | $38 | 1 payment
|
| Merck Sharp & Dohme | Rotateq | $21 | 1 payment
|
| Pfizer | Prevnar 20 | $20 | 1 payment
|
| GlaxoSmithKline | Bexsero | $17 | 1 payment
|
See all 4 published payments
| Sanofi Pasteur | Meals · 2025-10-16 | Beyfortus | $38 |
| GlaxoSmithKline | Meals · 2025-10-10 | Bexsero | $17 |
| Pfizer | Meals · 2025-06-13 | Prevnar 20 | $20 |
| Merck Sharp & Dohme | Meals · 2025-06-02 | Rotateq | $21 |
See earlier years (2024, 2023, 2022, 2021, 2020)
2024: $78
| Merck Sharp & Dohme | Gardasil | $38 | 2 payments
|
| Sanofi Pasteur | Menquadfi | $21 | 1 payment
|
| Cranial Technologies | Doc Band | $19 | 1 payment
|
2023: $107
| Sobi | Synagis | $24 | 1 payment
|
| Tris Pharma | Dyanavel Xr | $23 | 1 payment
|
| Sanofi Pasteur | Menquadfi | $22 | 1 payment
|
| Merck Sharp & Dohme | M-M-R II | $19 | 1 payment
|
| GlaxoSmithKline | Bexsero | $18 | 1 payment
|
2022: $101
| Sobi | Synagis | $27 | 1 payment
|
| Sanofi Pasteur | Vaxelis | $26 | 1 payment
|
| Cranial Technologies | Doc Band | $17 | 1 payment
|
| Merck Sharp & Dohme | Gardasil 9 | $16 | 1 payment
|
| GlaxoSmithKline | Bexsero | $15 | 1 payment
|
2021: $28
| Cranial Technologies | Doc Band | $28 | 2 payments
|
2020: $11
| Merck Sharp & Dohme | Rotateq | $11 | 1 payment
|
Professional record
- NPI
- 1396921060
- Licence
- AZ 60225, MI 4301089886, PA MD-440361
More record details
- Sole proprietor
- No
- Taxonomy
- Pediatrics (208000000X)
- Mailing address
- Po Box 276950, Sacramento, CA, 95827
- NPI first listed
- 2008-01-12
- NPI last updated
- 2026-08-25
- NPI record certified
- 2026-08-25
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 830 5th Ave, Chambersburg, PA, 17201